Get started
Author

V. Portelance

Observed names: Portelance, Portelance, Vincent, V PORTELANCE, V Portelance, V. PORTELANCE, VINCENT PORTELANCE
OpenAlex ID: A5015171559
BCG in cancer immunotherapy
1976 · Armand Frappier, G Lamoureux, et al. · Grune & Stratton eBooks · 79
Chemical and biological characterization of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus isolated from urogenital flora
1984 · M Frenette, R Beaudet, et al. · Infection and Immunity · 21
THE SYNTHESIS OF dl-ARMEPAVINE1
1950 · LÉO MARION, LIONEL LEMAY, et al. · The Journal of Organic Chemistry · 17
Classification of Vitamin K-deficient Mutants of Staphylococcus aureus
1971 · A. SaSarman, M. Surdeanu, et al. · Journal of General Microbiology · 16
Role of Menaquinone in Nitrate Respiration in Staphylococcus aureus
1974 · A. Sasarman, Peggy Purvis, et al. · Journal of Bacteriology · 15
Comparative Study of the Free Lipids of Eight BCG Daughter Strains
1974 · J. Asselineau, V. Portelance · Recent results in cancer research/Recent Results in Cancer Research · 15
Vitamin K-deficient Mutants of Bacteria
1969 · A. SASARMAN, M. SURDEANU, et al. · Nature · 15
Protection of cotton rats against experimental Echinococcus multilocularis infections with BCG cell walls
1979 · J M Reuben, C E Tanner, et al. · Infection and Immunity · 14
PDF
Toxic effects of massive doses of BCG in mice, guinea pigs, and monkeys
1976 · V. Portelance, M. Quevillon, et al. · Cancer Immunology Immunotherapy · 8
Factors affecting the immunizing activity of ribosomal fractions isolated from Mycobacterium tuberculosis var. bovis strain BCG
1975 · V. Portelance, R. Brasseur, et al. · Canadian Journal of Microbiology · 7
Evaluation of the immunogenicity of a CaCl2 extract from Neisseria meningitidis group Y
1982 · J. G. Bisaillon, G. McSween, et al. · Canadian Journal of Microbiology · 5
Site of action of a gonococcal growth inhibitor produced by Staphylococcus haemolyticus
1988 · M. Frenette, R. Beaudet, et al. · Journal of Medical Microbiology · 4
Comparison of the in vivo multiplication of 10 BCG substrains in three strains of mice: no correlation with their antitumour activity.
1983 · M Frenette, V Portelance, et al. · PubMed · 4
In vitro inhibition of Neisseria gonorrhoeae growth by a urogenital strain of Streptococcus faecalis.
1985 · D Dubreuil, J G Bisaillon, et al. · PubMed · 3
Stimulation of non-specific anti-tumour resistance in the mouse using cell wall preparations from four BCG substrains
1983 · R. Beaudet, M. Frenette, et al. · Annales de l Institut Pasteur Immunologie · 3
Growth retardation and prevention of Ehrlich solid tumor by Clostridium perfringens type A spores and culture supernatant.
1978 · J R Lapointe, V Portelance · PubMed · 3
Induction of antituberculous immunity by polysaccharidic contaminants of crude ribosomal vaccines isolated from Mycobacterium bovis, strain BCG.
1977 · V Portelance, R P Boulanger, et al. · PubMed · 3
Preservation of mycobacterial suspensions at −55 °C
1975 · R. P. Boulanger, V. Portelance · Canadian Journal of Microbiology · 3
Mice tuberculosis quantified by the lung density technique
1974 · V. Portelance, R. P. Boulanger, et al. · Canadian Journal of Microbiology · 3
Some biologic properties of myobacteria following the extraction of lipids; the power to initiate acquired resistance.
1959 · A FRAPPIER, V PORTELANCE, et al. · PubMed · 3
Research with labeled Mycobacteria. IX. Distribution of labeled phospholipids extracted from BCG in normal and vaccinated guinea pig.
1955 · J STERNBERG, V PORTELANCE · PubMed · 2
A potential polyvalent Neisseria meningitidis vaccine based on a mixture of CaCl2 cell extracts from groups A, B and Y.
1989 · J G Bisaillon, G McSween, et al. · PubMed · 1
Biochemical characterization of three mycobacterial ribosomal fractions
1983 · V. Portelance, R. Beaudet · Canadian Journal of Microbiology · 1
Nonphosphorus contaminants of mycobacterial phospholipid preparations.
1971 · V Portelance, J Asselineau · PubMed · 1
La sensibilité de l'épreuve de protection du cobaye vacciné par le BCG. I. Influence de l'age ou de faibles marges de viabilité des cultures de BCG.
1967 · Armand Frappier, V. Portelance, et al. · EspaceINRS (National Institute for Scientific Research (Canada)) · 1
Works count: 43
Citation count: 255
H-index: 8
I10-index: 8
Year
Topic
Type